E. Hammond

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy

David Nolan, E. Hammond, A. Martin et al. · AIDS · 2003 · 266 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study

Vijayaprakash Suppiah, Silvana Gaudieri, Nicola J. Armstrong et al. · PLoS Medicine · 2011 · 180 citations · Full text

Medicine, Immunology, Molecular Genetics +11

Contribution of Nucleoside-Analogue Reverse Transcriptase Inhibitor Therapy to Lipoatrophy from the Population to the Cellular Level

David Nolan, E. Hammond, Ian James et al. · Antiviral Therapy · 2003 · 129 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Accumulation of Mitochondrial DNA Mutations in Human Immunodeficiency Virus–Infected Patients Treated with Nucleoside-Analogue Reverse-Transcriptase Inhibitors

A. Martin, E. Hammond, David Nolan et al. · The American Journal of Human Genetics · 2003 · 90 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +14

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry

Emily C. O’Brien, Matthew T. Roe, Elizabeth Fraulo et al. · American Heart Journal · 2013 · 85 citations

Medicine, Cardiology, Preventive Medicine +13